Lincoln Pharmaceuticals informs about disclosure

23 Feb 2024 Evaluate
Lincoln Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Renukaben Maheshbhai Patel & PACs.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

575.50 1.25 (0.22%)
17-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.